Active Biotech AB (OSTO:ACTI) Other Long-Term Liabilities : kr2.70 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Active Biotech AB Other Long-Term Liabilities?

Active Biotech AB's other long-term liabilities for the quarter that ended in Mar. 2024 was kr2.70 Mil.

Active Biotech AB's quarterly other long-term liabilities declined from Sep. 2023 (kr3.40 Mil) to Dec. 2023 (kr0.00 Mil) but then increased from Dec. 2023 (kr0.00 Mil) to Mar. 2024 (kr2.70 Mil).

Active Biotech AB's annual other long-term liabilities declined from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr0.00 Mil) but then stayed the same from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil).

Active Biotech AB Other Long-Term Liabilities Historical Data

The historical data trend for Active Biotech AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Other Long-Term Liabilities Chart

Active Biotech AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Active Biotech AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Active Biotech AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Active Biotech AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Active Biotech AB (OSTO:ACTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OSTO:ACTI) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

BTPC:Germany

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.activebiotech.com

Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (OSTO:ACTI) Headlines

No Headlines